# What a Mouse Lifespan Study of Epitalon Actually Measured

- Article ID: research-100
- Product: Epitalon (epitalon-565)
- Canonical page: https://heritagebiolabs.com/research-library/articles/100-what-a-mouse-lifespan-study-of-epitalon-actually-measured
- Product collection: https://heritagebiolabs.com/research-library/products/epitalon
- Product page: https://heritagebiolabs.com/product/epitalon-565
- Reading focus: Methods & identity (Reading focus is a navigational tag, not an evidence grade.)
- Source years: 2003, 2026

> Educational article about published research. For research use only; not medical advice. Literature does not establish the identity, purity or activity of a purchased lot, and studies of individual components do not validate a blend.

A peptide is a short chain of amino acids joined by peptide bonds. Scientists can study its effects at several levels, from cell behavior to changes across an animal's lifetime. Epitalon is a four-residue peptide, also known by its sequence abbreviation AEDG. Longevity is one reason it has attracted research interest. The older controlled mouse study described here is a direct source for that question; more recent laboratory findings about telomeres do not measure survival. [1, 2]

Vladimir Anisimov and colleagues followed two groups of female Swiss-derived SHR mice until natural death. Each group began with 54 animals. One group received the peptide and the comparison group received saline. The investigators tracked survival, food intake, body weight and several other outcomes. They reported no change in mean lifespan. They did report higher survival measures for the last tenth of the animals and an increase in maximum observed lifespan in the peptide group. Those statistics answer different questions. The mean summarizes the full group, while the last tenth describes a handful of survivors. [1]

The authors also reported differences in some reproductive and chromosome measurements. Total spontaneous tumor incidence did not change, although a specific type of tumor was less frequent. Looking at many measurements can identify leads for follow-up. It also makes it especially useful to know which outcomes were set in advance and whether the same effects recur in independent experiments. [1]

The population and exposure were specific to this experiment. Neither the longest-lived mouse nor an average among late survivors can show how an adult human would respond. The most accurate description is that this study observed some differences in an animal cohort without finding an increase in average lifespan. It provides a basis for research questions, not a basis for promising additional years of life. [1, 2]

## Sources

1. Anisimov VN et al. Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice. Biogerontology (2003). <https://pubmed.ncbi.nlm.nih.gov/14501183/>
2. US Food and Drug Administration. FDA Briefing Document for Epitalon-Related Bulk Drug Substances. Pharmacy Compounding Advisory Committee (2026-07-23). <https://www.fda.gov/media/193345/download>

## Provenance

Article titles, body paragraphs and numbered citations extracted without rewriting from owner-supplied Word volumes. Product mappings use exact catalog labels; reading-focus tags and excerpts are navigational metadata. No independent peer-review or comprehensive source verification is claimed. Source volume: Peptide Research Articles 020 - DSIP and Epitalon.docx; article 100; content SHA-256 7869be468ffbd0c81215af3975a140a41cac8673243c5b53d1343b5a47827d7b.
